SARS-CoV-2 vaccines in patients with SLE #MMPMID33685998
Tang W; Askanase AD; Khalili L; Merrill JT
Lupus Sci Med 2021[Mar]; 8 (1): ä PMID33685998show ga
As the Moderna (mRNA-1273) and Pfizer/BioNTech (BNT162b2) vaccines become available to patients with autoimmune diseases and SLE, practitioners will have to inform them about the safety and efficacy of these vaccines. Here we discuss the challenges of applying vaccine data to patients with autoimmune diseases and the evidence available in the literature that may help in the decision process.